Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice

Circulation
T CyrusC D Funk

Abstract

The enzyme 12/15-lipoxygenase (12/15-LO) has been implicated in the oxidative modification of LDL. In a murine model, we tested the hypothesis that deletion of 12/15-LO decreases atherogenesis by reducing oxidant stress, as measured by 2 indices of lipid peroxidation: isoprostane generation and autoantibody formation to malondialdehyde (MDA)-LDL, an epitope of LDL formed as a result of oxidative modification. 12/15-LO-deficient (12/15-LO(-/-)) mice were crossed with apolipoprotein E-deficient (apoE(-/-)) mice. At 10 weeks of age, atherosclerotic lesion initiation was significantly delayed in the double-knockout mice. The rate of lesion progression was diminished at 8 and 12 months, and even at 15 months, lesion size was reduced 50% (P<0.0005) compared with control apoE(-/-) mice. The urinary and plasma levels of the specific isoprostane 8,12-iso-iPF(2alpha)-VI, as well as IgG autoantibodies against MDA-LDL, were significantly reduced in the double-deficient mice in parallel with decreased atherosclerosis at all time points from 10 weeks to 15 months of age compared with apoE(-/-) controls. Enzymatic action of 12/15-LO contributes significantly to atherosclerotic lesion initiation and propagation in this murine model. Strong pos...Continue Reading

References

Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S D CushingA M Fogelman
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S Ylä-HerttualaD Steinberg
Jul 1, 1995·The Journal of Clinical Investigation·V A FolcikM K Cathcart
Sep 17, 1994·Lancet·J L Witztum
Mar 1, 1997·The Journal of Clinical Investigation·H KühnC Gniwotta
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·S HörkköJ L Witztum
Oct 23, 1997·Current Opinion in Lipidology·J W Heinecke
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·D PraticòG A FitzGerald
Dec 5, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D PraticòG A Fitzgerald
Jan 14, 1999·The New England Journal of Medicine·R Ross
Jun 8, 1999·The Journal of Clinical Investigation·T CyrusC D Funk
Aug 24, 1999·The Journal of Biological Chemistry·J A LawsonG A FitzGerald
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·H LiG A FitzGerald
May 19, 2000·Experimental Gerontology·P D ReavenJ L Witztumc
Oct 12, 2000·The Journal of Biological Chemistry·R K TangiralaD J Rader

❮ Previous
Next ❯

Citations

Sep 18, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Stefan Uderhardt, Gerhard Krönke
Dec 4, 2003·Bioorganic & Medicinal Chemistry·Lise-Lotte GundersenOle Benny Østby
Mar 24, 2004·Chemistry and Physics of Lipids·Domenico PraticòGarret A FitzGerald
Dec 9, 2003·Trends in Molecular Medicine·Ozgur Kutuk, Huveyda Basaga
Jun 22, 2005·Prostaglandins & Other Lipid Mediators·Lorraine M SordilloIsis K Mullarky
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Colin D FunkLei Zhao
Jun 25, 2002·Molecular Aspects of Medicine·Helen R GriffithsSiân B Astley
Feb 11, 2003·Journal of the American College of Cardiology·Sotirios TsimikasJoseph L Witztum
Nov 1, 2001·Trends in Cardiovascular Medicine·C D Funk, T Cyrus
Nov 1, 2001·Trends in Cardiovascular Medicine·J L Witztum, D Steinberg
Nov 30, 2002·Trends in Cardiovascular Medicine·Alexey V KhrenovEvgueni L Saenko
Oct 29, 2002·Trends in Immunology·David R Greaves, Keith M Channon
Nov 27, 2002·Vascular Pharmacology·Wendy JessupLen Kritharides
Sep 23, 2011·Chemical Reviews·Jesper Z Haeggström, Colin D Funk
Jul 26, 2005·Nature Reviews. Drug Discovery·Colin D Funk
Jan 2, 2004·The New England Journal of Medicine·James H DwyerMargarete Mehrabian
Feb 12, 2008·The Journal of Biological Chemistry·Richard HarkewiczYury I Miller
Jun 24, 2009·The Journal of Experimental Medicine·Yosuke KayamaIssei Komuro
Nov 6, 2009·Antioxidants & Redox Signaling·Irena LevitanPapasani V Subbaiah
Jun 19, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Aksam J MerchedLawrence Chan
Mar 14, 2002·Current Opinion in Lipidology·Sonal S ShethAldons J Lusis
Mar 14, 2002·Current Opinion in Lipidology·Menno P J de Winther, Marten H Hofker
May 19, 2011·Current Opinion in Clinical Nutrition and Metabolic Care·Marcos Martínez-ClementeEsther Titos
Apr 3, 2012·American Journal of Physiology. Heart and Circulatory Physiology·Tamas KriskaWilliam B Campbell
Apr 9, 2011·Journal of Nutrigenetics and Nutrigenomics·Aksam J MerchedLawrence Chan
Jul 23, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Angela M TaylorColeen A McNamara
Jul 19, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Melissa H NagelinCatherine C Hedrick
Mar 28, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Ginny L WeibelGeorge H Rothblat
Jun 17, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Klaus LeyCatherine C Hedrick
Sep 1, 2012·Circulation Research·Sangderk LeeJudith A Berliner
Dec 10, 2002·American Journal of Respiratory and Critical Care Medicine·Jason D Morrow, L Jackson Roberts
Oct 2, 2012·BMC Complementary and Alternative Medicine·Fawzi M MahomoodallyMuhammad Iqbal Choudhary
Apr 18, 2012·Journal of Lipid Research·Shahzada AmirChristoph J Binder
Nov 20, 2012·Journal of Lipid Research·Daniel S KimGail P Jarvik
Nov 18, 2008·Journal of Lipid Research·Daniel Steinberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.